ClinicalTrials.Veeva

Menu

The Heidelberg Engineering ANTERION Anterior Segment Cornea and IOL Precision and Agreement Study

H

Heidelberg Engineering

Status

Completed

Conditions

Cornea Abnormality
Cataract
IOL
Post-Keratorefractive Surgery
Healthy Eye

Treatments

Device: ANTERION

Study type

Observational

Funder types

Industry

Identifiers

NCT04130490
B-2018-5

Details and patient eligibility

About

This is a prospective clinical study that will be conducted at one clinical site located in the United States to assess anterior segment parameters with the ANTERION

Enrollment

176 patients

Sex

All

Ages

22+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Age 22 years or older

  2. Able and willing to undergo the test procedures, sign informed consent, and follow instructions

  3. Able to fixate

  4. With the following eye pathology status for the individual eye population:

    • A. Eye with normal anterior segment and crystalline lens
    • B. Eye with a cataract of grade 1.5 or higher
    • C. Eye with abnormal corneal shape
    • D. Eye with status post-keratorefractive surgery
    • E. Eye without a crystalline lens

Exclusion criteria

  1. Subjects which were enrolled in the B-2018-1 clinical study

  2. Active infection or inflammation in the study eye

  3. Insufficient tear film or corneal reflex

  4. Physical inability to be properly positioned at the study devices or eye exam equipment

  5. Rigid contact lens wear 2 weeks prior to imaging

  6. Soft lenses worn within one hour prior to imaging

  7. With the following eye pathology status for the individual eye population:

    • A. Eye meets eligibility criteria for eye populations B, C, D or E
    • B. Eye meets eligibility criteria for eye populations C,D or E
    • C. Eye meets eligibility criteria for eye populations D or E
    • E. Eye with abnormal corneal shape (except status post-keratorefractive surgery)

Trial design

176 participants in 5 patient groups

Eye with normal Anterior Segment
Description:
3 repeat measurements on each of the 3 investigational and reference devices
Treatment:
Device: ANTERION
Eye with cataract
Description:
3 repeat measurements on each of the 3 investigational and reference devices
Treatment:
Device: ANTERION
Eye with corneal abnormality
Description:
3 repeat measurements on each of the 3 investigational and reference devices
Treatment:
Device: ANTERION
Eye with status post-keratorefractive surgery
Description:
3 repeat measurements on each of the 3 investigational and reference devices
Treatment:
Device: ANTERION
Eye without a crystalline lens
Description:
3 repeat measurements on each of the 3 investigational and reference devices
Treatment:
Device: ANTERION

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems